Clinical Trial Update: A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study evaluating AK112 in combination with VG2025 for colorectal cancer with liver metastases; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• AK112
• VG2025

Snippet

Sponsor: Akeso | Conditions: Colorectal Cancer With Hepatic Metastases | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING